DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,036 filers reported holding DANAHER CORPORATION in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $10,359,000 | -10.3% | 74,843 | -0.6% | 1.36% | +17.7% |
| Q4 2019 | $11,552,000 | +1.2% | 75,270 | -4.7% | 1.16% | +0.5% |
| Q3 2019 | $11,410,000 | +1.5% | 79,003 | +0.5% | 1.15% | -0.8% |
| Q2 2019 | $11,238,000 | +8.1% | 78,628 | -0.6% | 1.16% | +8.3% |
| Q1 2019 | $10,396,000 | +72.5% | 79,103 | +35.3% | 1.07% | +0.5% |
| Q4 2018 | $6,027,000 | -5.9% | 58,449 | -0.8% | 1.06% | +6.8% |
| Q3 2018 | $6,402,000 | +9.4% | 58,920 | -0.6% | 1.00% | +0.6% |
| Q2 2018 | $5,850,000 | +1.7% | 59,280 | +0.8% | 0.99% | -0.5% |
| Q1 2018 | $5,755,000 | +5.6% | 58,781 | +0.1% | 1.00% | +6.5% |
| Q4 2017 | $5,452,000 | +7.9% | 58,741 | -0.2% | 0.93% | +2.5% |
| Q3 2017 | $5,051,000 | -6.3% | 58,883 | -7.9% | 0.91% | -6.8% |
| Q2 2017 | $5,393,000 | -1.2% | 63,908 | +0.1% | 0.98% | -0.9% |
| Q1 2017 | $5,460,000 | +11.5% | 63,833 | +1.5% | 0.99% | +7.2% |
| Q4 2016 | $4,897,000 | +0.3% | 62,915 | +1.0% | 0.92% | -1.5% |
| Q3 2016 | $4,883,000 | -26.8% | 62,287 | -5.6% | 0.93% | -27.9% |
| Q2 2016 | $6,667,000 | +5.6% | 66,010 | -0.8% | 1.30% | +2.4% |
| Q1 2016 | $6,312,000 | -0.3% | 66,542 | -2.4% | 1.26% | -3.2% |
| Q4 2015 | $6,331,000 | +8.8% | 68,158 | -0.1% | 1.31% | +3.6% |
| Q3 2015 | $5,820,000 | -0.8% | 68,241 | +2.1% | 1.26% | +7.0% |
| Q2 2015 | $5,867,000 | +19.1% | 66,841 | +15.2% | 1.18% | +23.2% |
| Q1 2015 | $4,926,000 | -3.7% | 58,021 | -2.8% | 0.96% | -4.6% |
| Q4 2014 | $5,114,000 | +6.6% | 59,669 | -5.5% | 1.00% | +0.3% |
| Q3 2014 | $4,799,000 | -4.1% | 63,167 | -1.1% | 1.00% | -3.4% |
| Q2 2014 | $5,004,000 | +4.6% | 63,844 | +0.1% | 1.04% | -1.7% |
| Q1 2014 | $4,785,000 | +2.5% | 63,802 | +5.5% | 1.05% | +0.5% |
| Q4 2013 | $4,669,000 | +10.7% | 60,477 | -0.6% | 1.05% | +1.7% |
| Q3 2013 | $4,219,000 | +7.8% | 60,861 | -1.6% | 1.03% | +0.9% |
| Q2 2013 | $3,915,000 | – | 61,846 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |